Clinical Trial Update: A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing mometasone (Test or Reference) for mild to moderate persistent allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• To Moderate Persistent Allergic Rhinitis

Drugs mentioned

• mometasone (mometasone)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Mild to Moderate Persistent Allergic Rhinitis | Phase 3 | Status: COMPLETED